Page last updated: 2024-10-27

gliclazide and Arrhythmias, Cardiac

gliclazide has been researched along with Arrhythmias, Cardiac in 2 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, TM1
Parsons, RW1
Broadhurst, RJ1
Hobbs, MS1
Jamrozik, K1
Ballagi-Pordány, G1
Köszeghy, A1
Koltai, MZ1
Aranyi, Z1
Pogátsa, G1

Other Studies

2 other studies available for gliclazide and Arrhythmias, Cardiac

ArticleYear
Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment.
    Diabetes care, 1998, Volume: 21, Issue:4

    Topics: Adult; Arrhythmias, Cardiac; Diabetes Complications; Diabetes Mellitus; Digitalis Glycosides; Diuret

1998
Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds.
    Diabetes research and clinical practice, 1990, Volume: 8, Issue:2

    Topics: Animals; Arrhythmias, Cardiac; Blood Glucose; Carbutamide; Dose-Response Relationship, Drug; Electro

1990